Product Information
VENLAFAXINE HCL 50 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0979 per EA under NDC 00093914901. Its NADAC has been published 315 times since Jun 17, 2020.
Strength
50 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093914901
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
VENLAFAXINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076690On Market Since
8/4/2006
Pharmacological Classes
Price Statistics
The NADAC for VENLAFAXINE HCL 50 MG TABLET has been published 315 times since Jun 17, 2020, and over the history we have for it it has declined 41.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0979 per EA |
|---|---|
| All-time high | $0.2087 (May 11, 2022) |
| All-time low | $0.0537 (Jan 18, 2023) |
| 52-week high | $0.0979 |
| 52-week low | $0.0797 |
| Median price | $0.0956 |
| Average price | $0.1134 |
| Largest weekly change | +66.0% (Jun 19, 2024) |
| Weeks tracked | 315 |
| Tracking since | Jun 17, 2020 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of VENLAFAXINE HCL 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE HCL 50 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.0979 per EA (NDC 00093914901), effective Jun 24, 2026.
How has the price of VENLAFAXINE HCL 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for VENLAFAXINE HCL 50 MG TABLET has declined 41.6%. It has been tracked across 315 weekly CMS publications since Jun 17, 2020.
What are the highest and lowest recorded NADAC prices for VENLAFAXINE HCL 50 MG TABLET?
Since Jun 17, 2020, the NADAC for VENLAFAXINE HCL 50 MG TABLET has ranged from a low of $0.0537 (Jan 18, 2023) to a high of $0.2087 (May 11, 2022), with a median of $0.0956 per EA.
Are there cheaper alternatives to VENLAFAXINE HCL 50 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as VENLAFAXINE HCL 50 MG TABLET, but none are currently priced below it.
Who manufactures VENLAFAXINE HCL 50 MG TABLET?
VENLAFAXINE HCL 50 MG TABLET (NDC 00093914901) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification